U.S. TRADE OFFICE REVIEWING INDIA'S SUPREME COURT DRUG RULING

摘要

The United States has said it is considering its response to an Indian Supreme Court ruling that U.S. drug manufacturers warn is the latest sign of a "deteriorating" environment for intellectual property rights in the country. "We are . . . reviewing the Court's order. We look forward to continued engagement and successful collaboration with India on these issues," said Andrea Mead, a spokeswoman for the U.S. Trade Representative's office.